Sarepta Therapeutics Inc (SRPT)
Cash conversion cycle
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 857.84 | 783.83 | 531.82 | 700.34 | 1,335.80 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
| Cash conversion cycle | days | 857.84 | 783.83 | 531.82 | 700.34 | 1,335.80 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 857.84 + — – —
= 857.84
The cash conversion cycle of Sarepta Therapeutics Inc has shown fluctuations over the past five years, ranging from a high of 1,335.80 days on December 31, 2020, to a low of 531.82 days on December 31, 2022. This metric measures the time it takes for the company to convert its investments in inventory and other resources into cash flows from sales.
The decreasing trend from 2020 to 2022 indicates an improvement in the company's efficiency in managing its working capital and generating cash from its operations. However, the slight increase in the cash conversion cycle in 2023 and 2024 suggests that there may have been some challenges or delays in the company's cash conversion process during those years.
Overall, Sarepta Therapeutics Inc should continue to monitor and manage its cash conversion cycle effectively to ensure optimal utilization of its resources and maintain a healthy cash flow position.
Peer comparison
Dec 31, 2024